Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jul 29:2018:5162162.
doi: 10.1155/2018/5162162. eCollection 2018.

Diabetes Device Use and Glycemic Control among Youth with Type 1 Diabetes: A Single-Center, Cross-Sectional Study

Affiliations

Diabetes Device Use and Glycemic Control among Youth with Type 1 Diabetes: A Single-Center, Cross-Sectional Study

Khalid Sheikh et al. J Diabetes Res. .

Abstract

Aim: The purpose of this cross-sectional study was to determine the rates of diabetes device use (insulin pump and continuous glucose monitor (CGM)) and association with glycemic control in youth with type 1 diabetes in a large, diverse pediatric center.

Methods: Demographic and clinical data were obtained from 1992 patients who met the eligibility criteria (age < 26 years, diabetes duration ≥ 1 year, and ≥1 clinic visit in the preceding 12 months). Statistical analyses assessed the likelihood of device use based on demographic characteristics and the association between device use and glycemic control based on most recent hemoglobin A1c (HbA1c).

Results: Mean age was 13.8 ± 4.2 years, 50.7% were female, diabetes duration was 6.2 ± 4 years, and mean HbA1c was 8.7 ± 1.8%. Overall, 38.2% of patients were on pump therapy and 18.5% were on CGM. Patients who were non-Hispanic (NH) white, privately insured, and with primary English-speaking parent(s) had higher rates of insulin pump use, as well as CGM use (P < 0.001 for both). Female patients had higher rates of pump use only (P < 0.01). Private health insurance, NH white race/ethnicity, and CGM use were each associated with lower HbA1c (P = 0.03, <0.001, and <0.008, resp.).

Conclusion: At a large, diverse, pediatric diabetes center, disparities in diabetes device use were present across sex, race/ethnicity, health insurance coverage, and primary language of parent(s). CGM use was associated with lower HbA1c. Quality improvement efforts are underway to ensure improved access, education, and clinical programs for advanced diabetes devices for T1D patients.

PubMed Disclaimer

Figures

Figure 1
Figure 1
(a) Odds ratios of not using an insulin pump (95% confidence intervals). (b) Odds ratios of not using CGM (95% confidence intervals).
Figure 2
Figure 2
(a) Unadjusted HbA1c data by insurance type. (b) Unadjusted HbA1c data for insurance type analyzed by diabetes treatment regimen stratified by pump and/or CGM use. ∗∗∗ indicates P < 0.001; ns indicates not statistically significant.

References

    1. Nathan D. M., Genuth S., Lachin J., et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The New England Journal of Medicine. 1993;329(14):977–986. doi: 10.1056/nejm199309303291401. - DOI - PubMed
    1. Nathan D. M., Cleary P. A., Backlund J. Y., et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. The New England Journal of Medicine. 2005;353(25):2643–2653. doi: 10.1056/NEJMoa052187. - DOI - PMC - PubMed
    1. Fullerton B., Jeitler K., Seitz M., Horvath K., Berghold A., Siebenhofer A. Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews. 2014;(2, article CD009122) doi: 10.1002/14651858.CD009122.pub2. - DOI - PMC - PubMed
    1. American Diabetes Association. 6. Glycemic targets: standards of medical care in diabetes—2018. Diabetes Care. 2018;41(Supplement 1):S55–S64. doi: 10.2337/dc18-S006. - DOI - PubMed
    1. Miller K. M., Foster N. C., Beck R. W., et al. Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D exchange clinic registry. Diabetes Care. 2015;38(6):971–978. doi: 10.2337/dc15-0078. - DOI - PubMed

MeSH terms

LinkOut - more resources